June 9, 2025 3:11 pm ET RAHWAY, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has ap… [+11553 chars]Read More
US FDA Approves Mercks ENFLONSIA clesrovimabcfor for Prevention of Respiratory Syncytial Virus RSV Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season Merckcom
